Trancos Ventures logo

Trancos Ventures

North America, Illinois, United States, Lincolnshire

Description

Trancos Ventures is a venture capital firm invest in startup companies with a concentration on life science tools, therapeutics.

Investor Profile

Trancos Ventures has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Seed (25%)
  • Series B (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Life Science
  • Oncology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Trancos Ventures frequently co-invest with?

Bruker
North America, Massachusetts, United States, Billerica
Co-Investments: 1
Norwich Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
N
North America, California, United States, Los Angeles
Co-Investments: 1
Bossa Invest
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 1
Genoa Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Morgan Noble
North America, District of Columbia, United States, Washington
Co-Investments: 2
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
New York Ventures
North America, New York, United States, New York
Co-Investments: 2
IndieBio
North America, California, United States, San Francisco
Co-Investments: 1
True Ventures
North America, California, United States, Palo Alto
Co-Investments: 1

Which angels does Trancos Ventures often collaborate with?

ZC
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Trancos Ventures?

Ionpath

Menlo Park, California, United States

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.

BiotechnologyHealth CareHealth DiagnosticsMedical
Series BSep 24, 2020
Amount Raised: $18,000,000
TARA Biosystems

New York, New York, United States

TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery

BiotechnologyMedical
Series AJun 23, 2020
Amount Raised: $10,000,000
Filtricine

Santa Clara, California, United States

Filtricine provides new solution to cancer care via Targeted Nutrients Deprivation.

BiotechnologyHealth CareLife ScienceMedicalOncology
SeedOct 29, 2018
Amount Raised: $5,000,000
TARA Biosystems

New York, New York, United States

TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery

BiotechnologyMedical
Series AOct 16, 2017
Amount Raised: $9,000,000